TBMED aims to support med-tech companies in the development of high-risk medical devices by reducing their time-to-market for the European sector.

TBMED will help European SMEs to maintain their competitiveness and innovation capacity in the face of global competition, e.g. from larger providers. Its aim is to minimize time-to-market and efforts for reimbursement and make medical devices accessible to patients more easily.

Upcoming events

23rd EVER Congress

October 13, 2022 — October 15, 2022
Valencia, Spain

MEDICA 2022

November 14, 2022 — November 17, 2022
Düsseldorf, Germany

Facts and Figures

4 years
Duration

4 years

4 Countries
13 Partners

4 Countries

8.5 M €
Funding

8.5 M €

Consortium